Combined therapy with intravesical instillation of hydroxypropylcellulose-doxorubicin and local hyperthermia was performed in 11 patients with recurrent effect in the 11 patients treated.
There has been no effective modality to treat cancer of the urinary bladder, particularly recurrent and multiple cancers. This is particularly true when severe complications are present or when the patients have already received radiation therapy or systemic chemotherapy.
In such cases, total cystectomy or aggressive chemotherapy using methotrexate, vinblastin, doxorubicin and Cisplatin (M-VAC) are difficult to perform. We have been treating such difficult cases with local hyperthermic therapy together with local application of chemotherapeutic drugs and have observed favorable results1)2).
We have previously described the development of a membrane adhesive anti-cancer drug , hydroxypropylcellulose-doxorubicin (HPC-doxorubicin) 3). In the present report , we describe our encouraging results that instillation of HPC-doxorubicin into the urinary bladder and local hyperthermia treatment of the bladder is an effective means to treat recurrent bladder tumors .
Subjects and Methods
The subjects in the present study were 11 patients with a urinary bladder cancer who were referred to the Department of Urology, Nagoya City University School of Medicine during the period of 1987 -1990. There were 8 male and 3 female patients. The age distribution of the patients ranged between 45 and 85 years. All cases were recurrent cancer of the urinary bladder with a history of previous therapy: 6 patients had transurethral resection (TUR) , 2 partial cystectomy, 2 radiation therapy and 1 a combination of TUR, radiation and chemotherapy. Stage (TNM) and grade of the cancer before hyperthermia are shown in HPC-doxorubicin at 20 mg / 20 ml was instilled into the urinary bladder through the urethra, and hyperthermia was then given immediately with a Thermotron RF-8, a capacitive hyperthermia unit using 8 MHz-RF (Yamamoto Vinyter Co., Osaka, Japan) ( Fig. 1 ) . The characteristics of this machine have been reported elsewhere1)2)4). The RF was applied with a pair of 30 cm diameter electrodes coupled to the posterial and anterial surface of the pelvis. The temperature in the urinary bladder was determined using a thermosensor (thermocouple)
inserted into the bladder cavity through the urethra. A vinyl bolus containing physiological saline was placed between the electrode and the body surface.
In order to prevent the heating of the skin and subcutaneous tissues, the saline solution was cooled to 5°C by circulation through a heat exchanger.
Hyperthermia lasting 60 min. per session was given once or twice a week. One patient received chemo-hyperthermia only twice while the other 10 cases received the therapy 3 -9 times (Table 3) . Cystoscopy, cold punch biopsy, urine cytology, CT and IVU were performed before and after the treatment. HPC-doxorubicin was excreted spontaneously with urine after the instillation.
The therapeutic results were judged according to the following criteria: complete disappearance of evaluable abnormality; complete response (CR) ; more than 50 % reduction in evaluable abnormality, partial response (PR) ; 25 -50% reduction in evaluable abnormality, minor response (MR) ; less than 25 % reduction or increase in the evaluable abnormality; no change (NC) ; and more than 25% increase, progressive disease (PD) . Criteria for the posttreatment effects on carcinoma in situ have been described as follows: the complete response 
Clinical Result
The clinical results of treatment are shown in Table 3 . The overall results were CR in 6 cases, PR in 4 cases and NC in 1 case. The 4 PR cases which received TUR or total cystectomy are alive and tumor-free. Thus 4 PR and 6 PR out of a total of 11 patients treated are tumor-free as of this report. The duration of freedom from tumors is 8 -45 months and the survival duration is 8-45 months in the 11 cases.
Among 6 cases of T1, CR was observed in 4 cases, PR in 1 case and NC in 1 case. One PR case had a residual tumor which could be removed by TUR and the patient has been tumor-free for the past 39 months.
The NC case had severe complications from cardiac disease so that surgical operation of the urinary bladder was impossible. The tumor was subsequently treated with radiation therapy followed by intra-cystic administration of anticancer agent.
Out of 5 cases with T2 infiltrated cancer of the urinary bladder, 2 were CR and 3 were PR. All 3 PR cases agreed to receive total cystectomy . In one of the 3 PR cases, reconstruction of the neobladder was made using the ileocecal procedure.
In another (female) , a ureterosigmoidostomy was performed.
The remaining one case was a 73 years-old so that ileal conduit was selected. These 3 cases are tumor-free as of this report . All 5 T2 pa-tients are alive at the present time. The present study demonstrated that local hyperthermia in combination with intravesical instillation of chemotherapeutic drugs may be useful for the treatment of bladder cancer.
Discussion
The follow-up period for the present study is still less than 5 years with the longest survival period being 45 months.
Although it is still too early to make a final conclusion based on the study using only 11 patients, we are encouraged with our results. Investigations are in progress reveal whether another chemotherapeutic agent other than doxorubicin may be combined with hyperthermia to attain a more effective method of treatment.
This study was performed within the frame work of the study project "Efficacy and Clinical Application of Combined Hyperthermia and Chemotherapy" assigned to the Kano Group under the Ministry of Education scientific research program for fiscal 1991.
